Try our beta test site

Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2008 by Introgen Therapeutics.
Recruitment status was:  Recruiting
Sponsor:
Collaborator:
M.D. Anderson Cancer Center
Information provided by:
Introgen Therapeutics
ClinicalTrials.gov Identifier:
NCT00116363
First received: June 28, 2005
Last updated: March 28, 2008
Last verified: March 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2006
  Primary Completion Date: No date given